Clinical Trials Browser

Phase 2 × Mastocytosis, Cutaneous × trolamine salicylate × Clear all

NCT04846348 2024-04-25

Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis

Phase 2 Terminated

1 enrolled 7 charts

DermatologicMyeloid

Mastocytosis, Cutaneous